Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the ...

A surprise holdout by ultraconservative members of the House Budget Committee Thursday forced Speaker Mike Johnson to ...

Unlike Trump's first term, his proposed "most favored nation" policy, tying U.S. drug prices to the lowest prices paid by ...

Donald Trump has signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

U.S. President Donald Trump holds an executive order on prescription drug pricing next to U.S. Health and Human Services (HHS ...

President Donald Trump is attempting to slash drug prices for Americans by more closely aligning their costs to lower prices paid abroad, renewing and expanding upon a failed push from his first term.

President Donald Trump revived a controversial policy that aims to slash drug costs by tying the prices of some medicine in ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the lowest price they charge in other countries.

Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

Amid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...